Racette, Brad

Incidence of Parkinson disease in North America

Willis, A. W., Roberts, E., Beck, J. C., Fiske, B., Ross, W., Savica, R., Van Den Eeden, S. K., Tanner, C. M., Marras, C., on behalf of the Parkinson’s Foundation P4 Group, et al. (2022) · npj Parkinson's Disease

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 341

Variables associated with return to sport following anterior cruciate ligament reconstruction: a systematic review

Czuppon, S., Racette, B. A., Klein, S. E., & Harris-Hayes, M. (2014) · British Journal of Sports Medicine

Knee injuries and reconstruction techniquesSports injuries and prevention

Cited by 328

Pepinemab antibody blockade of SEMA4D in early Huntington’s disease: a randomized, placebo-controlled, phase 2 trial

Feigin, A., Evans, E. E., Fisher, T. L., Leonard, J. E., Smith, E. S., Reader, A., Mishra, V., Manber, R., Walters, K. A., Kowarski, L., et al. (2022) · Nature Medicine

Genetic Neurodegenerative DiseasesParkinson's Disease Mechanisms and Treatments

Cited by 67

Replication of association between ELAVL4 and Parkinson disease: the GenePD study

DeStefano, A. L., Latourelle, J., Lew, M. F., Suchowersky, O., Klein, C., Golbe, L. I., Mark, M. H., Growdon, J. H., Wooten, G. F., Watts, R., et al. (2008) · Human Genetics

Parkinson's Disease Mechanisms and TreatmentsGenetic Associations and Epidemiology

Cited by 40